SOD1 and endothelial dysfunction: In our study, treatment with the SOD mimetic tempol improved the impaired endothelium-dependent relaxations elicited by hyperoxaluria in preglomerular arteries, thus demonstrating that ROS are involved in hyperoxaluria-mediated endothelial dysfunction.